Medicine and Dentistry
Patient
100%
Kidney Graft
86%
Donor
78%
Transplantation
68%
Kidney Transplantation
51%
Kidney
40%
Therapeutic Procedure
37%
Tacrolimus
30%
Nephrectomy
29%
Neoplasm
25%
Everolimus
24%
Complication
23%
Kidney Function
21%
Incidence
20%
Follow up
20%
Acute Graft Rejection
17%
Cyclosporine
17%
Immunosuppressive Treatment
16%
Case Report
16%
Combination Therapy
15%
Quality of Life
15%
Non Melanoma Skin Cancer
15%
Bariatric Surgery
15%
Immunosuppressive Drug
14%
T Cell
13%
Evaluation Study
13%
Enalapril Maleate
11%
Systematic Review
11%
Mycophenolate Mofetil
11%
Graft Survival
11%
Organ Transplantation
11%
Self Concept
10%
Anxiety
10%
Recurrent Disease
10%
Perception
9%
Drive
9%
Kidney Allograft
9%
Corticosteroid
8%
Surgery
8%
Diseases
8%
Female
8%
Low Drug Dose
8%
Consensus
8%
Chronic Kidney Disease
8%
Basiliximab
7%
Atorvastatin
7%
Glycoprotein
7%
Cyst
7%
Left Ventricular Hypertrophy
7%
Peritoneal Fibrosis
7%
Pharmacology, Toxicology and Pharmaceutical Science
Everolimus
68%
Tacrolimus
55%
Immunosuppressive Agent
16%
Mycophenolate Mofetil
15%
Acute Graft Rejection
15%
Ciclosporin
15%
Atorvastatin
15%
Antibiotic Prophylaxis
15%
Acetylcysteine
13%
Antibiotic Agent
13%
Calcineurin Inhibitor
12%
Clinical Trial
12%
Basiliximab
12%
Rat
10%
Survival
9%
Surgical Infection
9%
Thymocyte Antibody
9%
Incidence
8%
Clinical Study
7%
Controlled Clinical Trial
7%
Heart Left Ventricle Hypertrophy
7%
Randomized Clinical Trial
7%
Atorvastatin
7%
Steroids
6%
Reperfusion Injury
6%
Wound
5%
Corticosteroid
5%
Cholesterol
5%
Creatinine
5%
Immunology and Microbiology
Transplantation
50%
Kidney
38%
Basiliximab
17%
Tacrolimus
15%
Everolimus
13%
Electric Potential
12%
Dose
11%
Antiphospholipid Syndrome
10%
Acute Graft Rejection
9%
Immunosuppressive Drug
7%
Renal Transplantation
7%
Life
7%
Anti-Thymocyte Globulin
7%
Cytomegalovirus
7%
Kidney Transplantation
7%
Insulin Resistance
7%
Antibody Response
7%
T Cell
7%
Insulin Sensitivity
7%
Adipose Tissue
7%
Consensus
6%
Ciclosporin
6%
Organ
5%
Mycophenolic Acid
5%
Immunosuppression
5%
